In the treatment of cardiometabolic disease, much has changed in the past 20 years, especially with the emergence of novel ...

Risankizumab outperformed vedolizumab in various outcomes, including clinical response at 12 and 52 weeks, among patients ...

Use of GLP-1 receptor agonists did not appear to affect esophageal function among patients with type 2 diabetes, according to ...

Of the 2.3 million women diagnosed annually with breast cancer worldwide, research shows more than half report having ...

Lab monkeys thought to have COVID-19, hepatitis C virus and herpes escaped after the transport vehicle carrying them ...

Reverting to pre-COVID telehealth policies could reduce access to care for kidney transplant recipients who live in ...

Adult patients with cancer who had adenomas at baseline and immune checkpoint inhibitor-mediated diarrhea and colitis faced a ...

Patients with autoimmune and rheumatic diseases who received antiviral therapy for COVID-19 demonstrated reduced incidence of ...

Use of teduglutide appeared safe for patients with short bowel syndrome, with no increased incidence of gastrointestinal ...

Progressive myopia is a growing issue in every country as near vision demands for children continue to increase. In 1980, ...

The FDA approved a label update for Winrevair to include that it lowers the risk for clinical worsening events in adults with ...

Patients with obesity and asthma who used GLP-1 receptor agonists had significantly fewer exacerbations and prednisone use ...